Search

Author/Creator Stringer-Reasor, Erica

1. Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. Issue 27 (20th September 2022)

Authors:
Henry, N. Lynn; Somerfield, Mark R.; Dayao, Zoneddy; Elias, Anthony; Kalinsky, Kevin; McShane, Lisa M.; Moy, Beverly; Park, Ben Ho; Shanahan, Kelly M.; Sharma, Priyanka; Shatsky, Rebecca; Stringer-Reasor, Erica; Telli, Melinda; Turner, Nicholas C.; DeMichele, Angela
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 27(2022)
Page Start:
3205
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CTIM-02. TIP: PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN'S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES. (14th November 2022)

Authors:
Shen, Colette; Abdou, Yara; Tan, Xianming; Gupta, Gaorav; Lynce, Filipa; Stringer-Reasor, Erica; Anders, Carey
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CTNI-02. TBCRC049: A PHASE II STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF TUCATINIB, TRASTUZUMAB AND CAPECITABINE FOR THE TREATMENT OF LEPTOMENINGEAL METASTASIS IN HER2 POSITIVE BR1AST CANCER. (9th November 2020)

Authors:
Murthy, Rashmi; O'Brien, Barbara; Berry, Donald; Navin, Nicholas; Johnson, Jason; Gule-Monroe, Maria; Leone, Jose; Specht, Jennifer; Melisko, Michelle; Morikawa, Aki; Storniolo, Anna; Brufsky, Adam; Pohlmann, Paula; Park, Deric; Park, Ben; Krop, Ian; Lin, Nancy; Rimawi, Mothaffar; Wolff, Antonio;...
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii41
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial). (August 2021)

Authors:
Mueller, Volkmar; Wardley, Andrew; Paplomata, Elisavet; Hamilton, Erika; Zelnak, Amelia; Fehrenbacher, Louis; Jakobsen, Erik; Curtit, Elsa; Boyle, Frances; Harder Brix, Eva; Brenner, Andrew; Crouzet, Laurence; Ferrario, Cristiano; Muñoz-Mateu, Montserrat; Arkenau, Hendrik-Tobias; Iqbal, Nayyer; A...
Journal:
European journal of cancer
Issue:
Volume 153(2021)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. Issue 1 (January 2022)

Authors:
Yau, Christina; Osdoit, Marie; van der Noordaa, Marieke; Shad, Sonal; Wei, Jane; de Croze, Diane; Hamy, Anne-Sophie; Laé, Marick; Reyal, Fabien; Sonke, Gabe S; Steenbruggen, Tessa G; van Seijen, Maartje; Wesseling, Jelle; Martín, Miguel; del Monte-Millán, Maria; López-Tarruella, Sara; Boughey, Ju...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 1(2022)
Page Start:
149
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗